Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers
- PMID: 10982604
- DOI: 10.1007/s005340050166
Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers
Abstract
Five hundred and fifty-two cases of primary carcinoma of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded) collected from 55 surgical centers were reviewed retrospectively. Three hundred seven patients (56%) had upper-third lesions (proximal carcinoma), whereas 71 (13%) and 101 (18%), respectively, had middle-third and lower-third bile duct carcinomas. The remaining patients had diffuse lesions. Resectability rates were 32% for upper-third localization compared with 47% and 51% for middle-third and lower-third localization, respectively. The operative mortality rate for proximal carcinomas was significantly lower with resection (16%) compared with palliative surgery (31%) (P<0.05). Overall 1 year survival (operative deaths excluded) was 68% after tumor resection compared to 31% after palliative surgery (P<0.001). Long-term results after surgical resection correlated with local and regional extension of the disease. The results of this study show that resection of extrahepatic bile duct carcinomas, particularly in an upper-third localization, is often associated with worthwhile long-term survival.
Similar articles
-
Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey.Ann Surg. 1991 Mar;213(3):236-41. doi: 10.1097/00000658-199103000-00010. Ann Surg. 1991. PMID: 1705417 Free PMC article.
-
One hundred and eleven liver resections for hilar bile duct cancer.J Hepatobiliary Pancreat Surg. 2000;7(2):135-41. doi: 10.1007/s005340050167. J Hepatobiliary Pancreat Surg. 2000. PMID: 10982605
-
Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.Cancer. 2005 Mar 15;103(6):1210-6. doi: 10.1002/cncr.20906. Cancer. 2005. PMID: 15685618
-
Current surgical treatment for bile duct cancer.World J Gastroenterol. 2007 Mar 14;13(10):1505-15. doi: 10.3748/wjg.v13.i10.1505. World J Gastroenterol. 2007. PMID: 17461441 Free PMC article. Review.
-
Surgical management of cholangiocarcinoma.Semin Liver Dis. 2004 May;24(2):189-99. doi: 10.1055/s-2004-828895. Semin Liver Dis. 2004. PMID: 15192791 Review.
Cited by
-
The updated Asia-Pacific consensus statement on the role of endoscopic management in malignant hilar biliary obstruction.Endosc Int Open. 2024 Sep 16;12(9):E1065-E1074. doi: 10.1055/a-2366-7302. eCollection 2024 Sep. Endosc Int Open. 2024. PMID: 39285860 Free PMC article.
-
[Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].Chirurg. 2004 Jan;75(1):59-65. doi: 10.1007/s00104-003-0747-y. Chirurg. 2004. PMID: 14740129 German.
-
Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma.Clin Exp Gastroenterol. 2019 Jun 6;12:255-262. doi: 10.2147/CEG.S207333. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 31239748 Free PMC article.
-
Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma.Oncotarget. 2017 Oct 23;8(62):105011-105019. doi: 10.18632/oncotarget.22054. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285229 Free PMC article.
-
The Landmark Series: Hilar Cholangiocarcinoma.Ann Surg Oncol. 2021 Aug;28(8):4158-4170. doi: 10.1245/s10434-021-09871-6. Epub 2021 Apr 7. Ann Surg Oncol. 2021. PMID: 33829358 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical